Eli Lilly

UnitedHealth Group

Johnson & Johnson

AbbVie

Merck

Abbott Labs

Thermo Fisher Scientific

Intuitive Surgical

Danaher

Amgen

Fidelity MSCI Health Care ETF

FHLC tracks a market-cap-weighted index of stocks in the broad US health care sector.

Fidelity Total Bond ETF

Fidelity Wise Origin Bitcoin Fund

Fidelity High Dividend ETF

Fidelity Enhanced Large Cap Growth ETF

Fidelity MSCI Information Technology Index ETF

In mid-November, Fidelity Investments joined the select ‘$100 billion in ETF assets' club. While the firm still has a sizable presence in the mutual fund world, Fidelity's ETFs have been gaining traction in 2024.

Fidelity Crosses $100 Billion ETF Milestone

iShares U.S. Healthcare ETF

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

Big stocks are likely to dominate the returns of the healthcare ETF going into Q3 earnings announcements.

What Lies in Store for Healthcare ETFs in Q3 Earnings?

The Fidelity MSCI Health Care Index ETF (FHLC) was launched on 10/21/2013, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

The Fidelity MSCI Healthcare Index ETF offers diversified exposure to healthcare, with a lower expense ratio and better performance than the Healthcare Select Sector SPDR Fund ETF. Economic uncertainty favors defensive sectors like healthcare, which is also expected to outperform IT in earnings growth for 2024. Despite potential short-term volatility, FHLC's defensive holdings, superior liquidity risk, and dividend grades make it a prudent buy, with a P/E ratio below the sector average.

FHLC ETF: Play Defensive For 2 Reasons

The healthcare sector has gained momentum lately on market rotation, with investors rushing to buy beaten-down stocks while shunning the hot technology sector.

What Lies in Store for Healthcare ETFs in Q2 Earnings?

Monthly article series reports aggregate industry metrics in healthcare. Healthcare providers and life science tools are moderately overvalued, while pharmaceuticals and biotechnology have the worst value and quality scores. Fidelity MSCI Health Care Index ETF is an equivalent to XLV for long-term investors.

FHLC: Healthcare Dashboard For July

Principal Healthcare Innovators Index ETF

First Trust Health Care AlphaDEX Fund

Amplify Treatments Testing & Advancements ETF

Global X Health Care Covered Call & Growth ETF

SPDR S&P Insurance ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Invesco DWA Healthcare Momentum ETF

Invesco S&P 500 Equal Weight Health Care ETF

SPDR Portfolio S&P 500 Growth ETF

SPDR Portfolio S&P 500 Value ETF

Amplify Weight Loss Drug & Treatment ETF

SPDR S&P Biotech ETF

SPDR S&P Health Care Equipment ETF

SPDR S&P Health Care Services ETF

SPDR S&P Pharmaceuticals ETF

Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?

Finding Opportunity in Unloved Healthcare ETFs

Bristol-Myers

Pfizer

While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.

Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?

iShares U.S. Healthcare Providers ETF

UnitedHealth Group (UNH) breezed past the Zacks Consensus Estimate on both earnings and revenues.

UnitedHealth Rises on Q1 Earnings Beat: ETFs to Gain

The healthcare sector is overvalued by 14% based on 11-year averages. Healthcare providers are not far from their valuation baseline, while the most overvalued subsector is healthcare equipment. Fast facts on Fidelity MSCI Health Care Index ETF, an alternative to XLV for long-term investors.

FHLC: Healthcare Dashboard For April

iShares Nasdaq Biotechnology ETF

VanEck Vectors Pharmaceutical ETF

The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to adjust drug prices in line with inflation, providing advantage in inflationary environment.

Healthcare In 2024: Navigating The Biopharma Bull Run

SPDR S&P 500 ETF Trust

After underperforming in 2023, the healthcare sector seems to be back on track at the start of the New Year. Healthcare generally outperforms during periods of low growth and high uncertainty.

Healthcare ETFs Start 2024 on a Positive Note

Technology continues to outperform, but defensive sectors like Utilities, Consumer Staples, and Healthcare may see increased interest. The Fidelity MSCI Health Care Index ETF offers broad exposure to the healthcare sector and has attracted significant assets. FHLC provides low-cost, diversified exposure to over 400 healthcare companies but has underperformed similar ETFs in terms of performance.

FHLC: Healthcare Can Work Well In 2024

Fidelity MSCI Health Care Index ETF owns a portfolio of 400 US healthcare stocks and should benefit from long-term growth in the sector. FHLC has performed comparably to the S&P 500 in the long run. FHLC's valuation is currently high and there is downside risk if an economic recession occurs, so investors may want to wait for a better entry point.

FHLC Is Vulnerable In An Economic Downturn Due To Its Rich Valuation And Portfolio Mix

Fidelity MSCI Telecommunication Services Index ETF

Earnings news is back on the menu for investors this week, and with that news comes ETFs to play those results. Whether it's Johnson & Johnson (JNJ), or Netflix (NFLX), ETFs can help.

Play Earnings News in Fidelity's Low-Fee ETF Suite

The healthcare industry's potential for long-term growth and stability could give FHLC a silver lining as the market trajectory remains somewhat uncertain. Despite underperforming during bull markets, FHLC has shown resilience during economic downturns, giving investors the option to trade some momentum for greater consistency in this ETF. This ETF's robust fundamentals and strong focus on leading healthcare names could make it a prime option for those with a longer-term outlook and lower risk tolerance.

FHLC: Long-Term Growth And Stability Make Healthcare A Low-Volatility Bet

FHLC possesses a large-cap, stable portfolio of diversified healthcare stocks, which enjoys a low expense ratio and strong price growth over the long run. Over the long-run, FHLC's delivered double-digit returns. This was possible as most of the large-cap stocks in which FHLC invested delivered strong returns. FHLC has a very low yield and is trading almost at par with its net asset value.

FHLC: A Stable Portfolio Of Healthcare Stocks Delivering Strong Returns

Fidelity MSCI Consumer Staples ETF

Exchange-traded funds provide investors with an easy way to diversify and minimize risk. The Fidelity MSCI Health Care Index ETF contains more than 430 of the top U.S. healthcare stocks.

Worried About the Markets? Buy and Hold These 2 Cheap ETFs.

Healthcare is considered a defensive sector that should outperform during times of high inflation, weak economic growth, and challenging markets. In addition, demographics should be a tailwind as the U.S. population is aging, and going forward, that trend is only accelerating.

FHLC: Aging U.S. Demographics Should Boost This Health Care ETF

The health care sector - as measured by the Fidelity Health Care ETF - outperformed the S&P 500 by ~12.2% over the past year. That's because health care is considered to be a relatively defensive sector due to the fact that healthcare - in general - cannot be delayed, no matter the economic environment.

FHLC: Because A Healthy Investor Holds Health Care Stocks

Global X Longevity Thematic ETF 

ARK Genomic Revolution Multi-Sector ETF

Virtus LifeSci Biotech Clinical Trials ETF

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

BlackRock Future Health ETF

Loncar Cancer Immunotherapy ETF

Global X Telemedicine & Digital Health ETF

First Trust NYSE Arca Biotechnology Index Fund

First Trust Nasdaq Pharmaceuticals ETF 

Global X Genomics & Biotechnology ETF

 Franklin Genomic Advancements ETF

ROBO Global Healthcare Technology and Innovation ETF

Invesco Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Medical Devices ETF

iShares Global Healthcare ETF

Global X Longevity Thematic ETF

First Trust Indxx Medical Devices ETF

Novo Nordisk

Invesco Dynamic Biotechnology & Genome ETF

Simplify Health Care ETF

Invesco Dynamic Pharmaceuticals ETF

Invesco S&P SmallCap Health Care ETF

ALPS Medical Breakthroughs ETF

Wisdomtree BioRevolution Fund

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

Can Health Care Stocks Outperform Again In 2023?

FHLC invests in health care stocks. Health care stocks are probably now fairly valued, although they remain cyclically well positioned.

FHLC: Health Care Stocks Are Probably Fairly Valued

Health Care is one of the "defensive" sectors that is generally thought to weather times of inflation/recession better than most. That's because many health care issues must be timely dealt with regardless of inflation/recession, many people have insurance, and health-care providers can pass on cost-inflation to consumers.

Will FHLC Keep Your Portfolio Fit?

The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfolio.

Healthcare ETFs in Focus Ahead of Q2 Earnings

Invesco Dynamic Energy Exploration & Production ETF

Invesco S&P 500 Equal Weight Consumer Staples ETF

Vanguard Energy ETF

Energy Select Sector SPDR Fund

Consumer Staples Select Sector SPDR Fund

Industry-focused ETFs can be a useful tool, but they're not always investors' best bet.

News for Fidelity MSCI Health Care ETF ETF (FHLC)